Stay updated on Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site’s UI/engine “Revision” value has been updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:06.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:28:35.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:44:49.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new site revision tag 'Revision: v3.4.2' is shown, while the older funding-status notice and the earlier 'Revision: v3.4.1' text have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:37:32.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A government funding/operating status notice was added and the site revision updated from v3.4.0 to v3.4.1; this change does not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:28:40.000Z thumbnail image

Stay in the know with updates to Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.